Paraneoplastic dermatomyositis associated with bladder cancer [1]

Lupus

Volumn 15, Issue 9, 2006, Pages 619-620

  Sabio, José Mario ^a   Vargas Hitos, J A ^a   Jimenez Alonso J ^a  

^a HOSPITAL UNIVERSITARIO VIRGEN DE LAS NIEVES   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; PREDNISONE;

BLADDER CANCER; CANCER RISK; CLINICAL FEATURE; DERMATOMYOSITIS; DIGITAL RECTAL EXAMINATION; DOSE RESPONSE; ELECTROMYOGRAPHY; HISTOPATHOLOGY; HUMAN; LABORATORY TEST; LETTER; MUSCLE BIOPSY; PRIORITY JOURNAL; TRANSURETHRAL RESECTION;

AGED; CARCINOMA, TRANSITIONAL CELL; DERMATOMYOSITIS; FATAL OUTCOME; HUMANS; MALE; NEOPLASM RECURRENCE, LOCAL; PARANEOPLASTIC SYNDROMES; PROSTATIC HYPERPLASIA; URINARY BLADDER NEOPLASMS;

EID: 33750513171     PISSN: 09612033     EISSN: None     Source Type: Journal    
DOI: 10.1177/0961203306071923     Document Type: Letter

References (15)

1. Hill CL, Zhang Y, Sigurgeirsson B, Pukkala E. Frequency of specific cancer types in der matomyositis and polymyositis: a population based-study. Lancet 2001; 357: 96-100.
2. Almog Y, Ben-Yehuda A, Ben-Chetrit E. Dermatomyositis associated with the recurrence of transitional cell carcinomas and Kaposi's sarcoma. Clin Exp Rheumatol 1991; 9: 285-288.
3. Marchal Escalona C, Vera Casano A, Chicharro Molero JA, Del Rosal Samaniego JM. Dermatomyositis as paraneoplastic syndrome of bladder tumor. Actas Urol Esp 1992; 16: 576-578.
4. Federman DG, Radonich M, Kirsner RS. Fatal bladder cancer and dermatomyositis. South Med 2000; 93: 492-493.
5. Robinson AJ, Alcock CJ. Dermatomyositis in association with transitional cell carcinoma of the bladder. Clin Oncol 2001; 13: 50-51.
6. García Donoso Garcia-Donoso C, Sanchez-Munoz A, Lopez-Medrano F. Dermatomyositis and transitional cell carcinoma of the bladder: a rare paraneoplastic syndrome associated with tumor recurrence. Eur J Intern Med 2003; 14: 397-398.
7. Mallon E, Osborne G, Dinneen M, Lane RJ. Dermatomyositis in association with transitional cell carcinoma of the bladder. Clin Exp Dermatol 1999; 24: 94-96.
8. Sekine H, Ohya K, Kojima S, Mizuguchi K. Dermatomyositis associated with urachal adenocarcinoma. J Urol 2002; 168: 1488-1489.
9. Russ BW, English JC 3rd, King DH, Halbach DP. Amyopathic dermatomyositis associated with transitional cell carcinoma of the bladder. Cutis 1999; 63: 73-76.
10. Hafejee A, Coulson IH. Dysphagia in dermatomyositis secondary to bladder cancer: rapid response to combined immunoglobulin and methylprednisolone. Clin Exp Dermatol 2005; 30: 93-94.
11. Rankin WR, Herman JR. Rapidly progressive transitional cell carcinoma associated with dermatomyositis. J Urol 2002; 167: 639-640.
12. Apaydin R, Gul U, Bahadir S, Siviloglu C, Ofluoglu I. Dermatomyositis without muscle weakness associated with transitional cellcarcinoma of the bladder. J Eur Acad Dermatol Venereol 2002; 16: 172-174.
13. Iskeceli O, Ozden B, Barlas G. Dermatomyositis in a case of carcinoma of the bladder. Tip Fak Mecm 1967; 30: 51-57 (in Turkish).
14. Barnes BE, Mawr B. Dermatomyositis and malignancy. A review of the literature. Ann Intern Med 1976; 84: 68-76.
15. Talanin NY, Bushore D, Rasberry, Rudolph T, Tuli M, Friedman-Muscante R. Dermatomyositis with features of inclusion body myositis with carcinoma of the bladder. Br J Dermatol 1999; 141: 926-930.